Stress Management Therapy for Triple Negative Breast Cancer
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Biobehavioral Stress Reduction Intervention for Triple Negative Breast Cancer?
While there is no direct evidence from the provided research articles about the effectiveness of Biobehavioral Stress Reduction Intervention specifically for Triple Negative Breast Cancer, studies highlight the importance of coping strategies and social support in improving the quality of life for breast cancer patients. These elements are often part of stress management therapies, suggesting potential benefits for patients undergoing such treatments.12345
How is the Biobehavioral Stress Reduction Intervention treatment different for triple-negative breast cancer?
The Biobehavioral Stress Reduction Intervention is unique because it focuses on managing stress and psychological well-being, which is important for triple-negative breast cancer patients who have limited treatment options and face high stress levels. Unlike traditional treatments that target the cancer directly, this therapy aims to improve patients' coping abilities and reduce psychological distress.23678
What is the purpose of this trial?
This clinical trial aims to see if patients with triple negative breast cancer can complete a biobehavioral stress reduction program that also addresses health related social needs (e.g., utilities, transportation, etc.). The stress reduction program is over ten weeks and includes stress reduction (e.g., progressive muscle relaxation), coping, problem solving, communication, and social support. Health related social needs will be evaluated at the beginning of the study, and referrals will be made to social work to help address those needs. The study will examine stress as reported by the patients and also use biological markers.
Research Team
Samilia Obeng-Gyasi, MD, MPH
Principal Investigator
Ohio State University Comprehensive Cancer Center
Eligibility Criteria
This trial is for adults over 18 with newly diagnosed, untreated triple negative breast cancer at stages I-III. It's not open to prisoners, men, certain ethnic groups, those who can't speak and understand English, or anyone with stage IV breast cancer or a history of DCIS or invasive breast cancer.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a biobehavioral stress reduction intervention over ten weeks, including stress reduction techniques, coping, problem solving, communication, and social support.
Follow-up
Participants undergo blood specimen collection and medical record review to assess stress and biomarkers.
Treatment Details
Interventions
- Biobehavioral Stress Reduction Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University Comprehensive Cancer Center
Lead Sponsor